GSK’s Cervarix became the top of ‘Female Vaccine

The GSK’s(Yoo-seok Hong, Korean Branch President) uterine cervical cancer preventive vaccines, ‘Cervarix,’ has acquired additional approval for indication of vaginal intra-epithelial neoplasia and vulvar intra-epithelial neoplasia prevention from the Ministry of Food and Drug Safety(hereinafter referring to MFDS).

Added contents are indication of prevention of human papillomavirus(HPV) 16 and ...